Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.

Ogiya, Akiko; Kimura, Kiyomi; Nakashima, Eri; Sakai, Takehiko; Miyagi, Yumi; Iijima, Kotaro; Morizono, Hidetomo; Makita, Masujiro; Horii, Rie; Akiyama, Futoshi; Iwase, Takuji

Ogiya, Akiko; Kimura, Kiyomi; Nakashima, Eri; Sakai, Takehiko; Miyagi, Yumi; Iijima, Kotaro; Morizono, Hidetomo; Makita, Masujiro; Horii, Rie; Akiyama, Futoshi; Iwase, Takuji.

Afiliação

Ogiya A; Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan. akiko.ogiya@jfcr.or.jp.
Kimura K; Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Nakashima E; Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Sakai T; Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Miyagi Y; Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Iijima K; Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Morizono H; Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Makita M; Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Horii R; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Akiyama F; Division of Pathology, Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan.
Iwase T; Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Breast Cancer ; 23(2): 318-22, 2016 Mar.

Article em En | MEDLINE | ID: mdl-25376341

Assuntos

Neoplasias da Mama/patologia; Carcinoma Ductal de Mama/secundário; Linfonodos/patologia; Recidiva Local de Neoplasia/epidemiologia; Biópsia de Linfonodo Sentinela; Adulto; Idoso; Idoso de 80 Anos ou mais; Axila; Biomarcadores Tumorais/metabolismo; Neoplasias da Mama/metabolismo; Neoplasias da Mama/cirurgia; Carcinoma Ductal de Mama/metabolismo; Carcinoma Ductal de Mama/cirurgia; Feminino; Seguimentos; Humanos; Técnicas Imunoenzimáticas; Incidência; Linfonodos/metabolismo; Linfonodos/cirurgia; Metástase Linfática; Pessoa de Meia-Idade; Invasividade Neoplásica; Recidiva Local de Neoplasia/patologia; Recidiva Local de Neoplasia/cirurgia; Estadiamento de Neoplasias; Prognóstico; Receptor ErbB-2/metabolismo; Receptores de Estrogênio/metabolismo; Receptores de Progesterona/metabolismo; Estudos Retrospectivos; Taxa de Sobrevida

Palavras-chave

Axillary recurrence; Breast cancer; Sentinel lymph node biopsy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma Ductal de Mama / Biópsia de Linfonodo Sentinela / Linfonodos / Recidiva Local de Neoplasia Tipo de estudo: Incidence_studies / Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google